WHAMM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.044000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.618200E-01
Normal-vs-Stage2
6.119800E-01
Normal-vs-Stage3
1.440830E-01
Normal-vs-Stage4
2.218000E-01
Stage1-vs-Stage2
7.734800E-01
Stage1-vs-Stage3
1.233920E-02
Stage1-vs-Stage4
3.141800E-02
Stage2-vs-Stage3
5.287900E-02
Stage2-vs-Stage4
1.731570E-01
Stage3-vs-Stage4
4.978800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.719200E-01
Normal-vs-AfricanAmerican
4.390000E-01
Normal-vs-Asian
8.918000E-01
Caucasian-vs-AfricanAmerican
6.102000E-01
Caucasian-vs-Asian
6.985400E-01
AfricanAmerican-vs-Asian
6.108800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.965200E-01
Normal-vs-Female
5.293400E-01
Male-vs-Female
9.840200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.963600E-01
Normal-vs-Age(41-60Yrs)
9.330800E-01
Normal-vs-Age(61-80Yrs)
3.104800E-01
Normal-vs-Age(81-100Yrs)
5.260400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.201200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.294010E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.346100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.577000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.556310E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.257200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.015800E-01
Normal-vs-Daily Drinker
3.937400E-01
Normal-vs-Weekly Drinker
2.894600E-01
Normal-vs-Occasional Drinker
4.206200E-01
Normal-vs-Social Drinker
6.552400E-01
Non Drinker-vs-Daily Drinker
5.359400E-01
Non Drinker-vs-Weekly Drinker
3.468400E-01
Non Drinker-vs-Occasional Drinker
7.491400E-01
Non Drinker-vs-Social Drinker
9.853600E-01
Daily Drinker-vs-Weekly Drinker
5.953600E-01
Daily Drinker-vs-Occasional Drinker
6.765000E-01
Daily Drinker-vs-Social Drinker
5.103000E-01
Weekly Drinker-vs-Occasional Drinker
3.338600E-01
Weekly Drinker-vs-Social Drinker
2.956400E-01
Occasional Drinker-vs-Social Drinker
7.332600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.313210E-01
Normal-vs-Grade 2
4.591700E-02
Normal-vs-Grade 3
2.866000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.267820E-01
Grade 1-vs-Grade 3
1.566180E-01
Grade 1-vs-Grade 4
1.313210E-01
Grade 2-vs-Grade 3
9.133000E-01
Grade 2-vs-Grade 4
4.591700E-02
Grade 3-vs-Grade 4
2.866000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.363200E-01
Normal-vs-NonDiabetic
5.571800E-01
Diabetic-vs-NonDiabetic
2.738000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.909200E-01
Normal-vs-NoPancreatitis
3.679200E-01
Pancreatitis-vs-NoPancreatitis
9.587900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.545600E-01
Normal-vs-N1
5.569600E-01
N0-vs-N1
3.598600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.178600E-01
Normal-vs-TP53-NonMutant
7.849600E-01
TP53-Mutant-vs-TP53-NonMutant
4.464400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
